Rituximab with alkylating agent in anti-myelin-associated glycoprotein neuropathy: A retrospective study of 26 cases

D Elessa; V Grosjean; P Lozeron; S Harel; B Royer; N Forgeard; F Thèves; A Talbot; M Malphettes; D Bengoufa; N Kubis; B Arnulf

doi:10.1111/bjh.19412

Rituximab with alkylating agent in anti-myelin-associated glycoprotein neuropathy: A retrospective study of 26 cases

Br J Haematol. 2024 Jun;204(6):2484-2486. doi: 10.1111/bjh.19412. Epub 2024 Mar 18.

Authors

D Elessa^{1

2}, V Grosjean^{2

3}, P Lozeron^{2

3}, S Harel^{1

2}, B Royer^{1

2}, N Forgeard^{1

2}, F Thèves^{1

2}, A Talbot^{1

2}, M Malphettes^{2

4}, D Bengoufa^{2

5}, N Kubis^{2

3}, B Arnulf^{1

2}

Affiliations

¹ Service d'Immuno-Hématologie, Assistance Publique - Hôpitaux de Paris, Hôpital Saint Louis, Paris, France.
² Université Paris Cité, Paris, France.
³ Service de Physiologie Clinique-Explorations Fonctionnelles, Assistance Publique - Hôpitaux de Paris, Hôpital Lariboisière, Paris, France.
⁴ Service d'Immuno-pathologie Clinique, Assistance Publique - Hôpitaux de Paris, Hôpital Saint Louis, Paris, France.
⁵ Laboratoire d'Immunologie, Assistance Publique - Hôpitaux de Paris, Hôpital Saint Louis, Paris, France.

PMID: 38500363
DOI: 10.1111/bjh.19412

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Alkylating Agents* / therapeutic use
Female
Humans
Male
Middle Aged
Myelin-Associated Glycoprotein* / immunology
Peripheral Nervous System Diseases* / drug therapy
Retrospective Studies
Rituximab* / therapeutic use

Substances

Alkylating Agents
Myelin-Associated Glycoprotein
Rituximab